Todd Carter

Insider Reports History

Entity
Individual
Location
C/O Voyager Therapeutics, Inc., 64 Sidney Street, Cambridge, MA
Signature
/s/ Scott MacDonald, as Attorney-in-Fact for Todd Carter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Todd Carter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Voyager Therapeutics, Inc. Chief Scientific Officer Common Stock 87.6K $655K $7.47 Feb 21, 2024 Direct
Voyager Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 77K Feb 9, 2024 Direct

Insider Reports Filed by Todd Carter

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VYGR Voyager Therapeutics, Inc. Feb 20, 2024 2 -$29.8K 4 Feb 22, 2024 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Feb 9, 2024 2 $0 4 Feb 16, 2024 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Jan 17, 2024 1 -$9.09K 4 Jan 19, 2024 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Sep 15, 2023 3 -$71.4K 4 Sep 18, 2023 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Jul 6, 2023 1 -$59.4K 4 Jul 10, 2023 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Jun 30, 2023 3 -$42.8K 4 Jul 5, 2023 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Mar 20, 2023 1 -$17K 4 Mar 22, 2023 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Feb 17, 2023 3 -$5.5K 4 Feb 22, 2023 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Feb 13, 2023 1 -$6.11K 4 Feb 15, 2023 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Jan 17, 2023 2 -$10.9K 4 Jan 19, 2023 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Jan 6, 2023 2 -$481 4 Jan 10, 2023 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Sep 19, 2022 1 $0 4 Sep 21, 2022 Chief Scientific Officer
VYGR Voyager Therapeutics, Inc. Sep 19, 2022 0 $0 3 Sep 21, 2022 Chief Scientific Officer